For multiple sclerosis.
Brand Name(s): Mavenclad
Generic Name: Cladribine
Instructions
Swallow the medicine without crushing or chewing it.
This medicine may be taken with or without food.
After taking other medicines, wait at least 3 hours before taking this medicine. Do not take any other medicines for 3 hours after this medicine.
Swallow with a full glass (8 oz) of water unless your doctor gives you different instructions.
This medicine will work best if you take it at about the same time every day.
Store at room temperature away from heat, light, and moisture. Do not keep in the bathroom.
If you miss a dose, contact your doctor for instructions.
Drug interactions can change how medicines work or increase risk for side effects. Tell your health care providers about all medicines taken. Include prescription and over-the-counter medicines, vitamins, and herbal medicines. Speak with your doctor or pharmacist before starting or stopping any medicine.
Tell your doctor if symptoms do not get better or if they get worse.
Keep using this medicine for the full number of days that it is prescribed. Do not stop the medicine even if you start to feel better.
Keep all appointments for medical exams and tests while on this medicine.
Cautions
Avoid touching any powder from a broken tablet. If the powder touches the skin, nose, or eyes, rinse thoroughly with water.
Wash your hands before and after handling this medicine.
Tell your doctor and pharmacist if you ever had an allergic reaction to a medicine.
Some patients on this medicine have developed severe, life-threatening infections. Please speak with your doctor about the risks and benefits of using this medicine.
This medicine may increase the risk of cancer. Ask your doctor about the benefits and risks.
Do not use the medication any more than instructed.
Call the doctor if there are any signs of confusion or unusual changes in behavior.
This medicine may reduce your body's ability to fight infections. Avoid contact with people with colds, flu or other infections. Contact your doctor if you develop fever, cough, sore throat, or chills.
Speak with your health care provider before receiving any vaccinations.
Do not breastfeed while on this medicine. You may safely start breastfeeding 10 days after stopping treatment.
Do not use this medicine if you are pregnant. If you become pregnant, contact your doctor immediately.
Women of childbearing age should have a negative pregnancy test before starting this medicine.
Women must use reliable forms of birth control while taking this medicine and for 6 months after stopping to prevent pregnancy.
Men with a female partner who is of childbearing age must use reliable birth control during sexual activity while taking this medicine and for 6 months after stopping to prevent pregnancy.
Women who are pregnant or in their childbearing years should not touch or handle this medicine. This medicine can be absorbed through the woman's skin and harm the unborn baby.
Do not share this medicine with anyone who has not been prescribed this medicine.
Some patients have serious side effects from this medicine. Ask your pharmacist to show you the information from the Food and Drug Administration (FDA) and discuss it with you.
Side Effects
The following is a list of some common side effects from this medicine. Please speak with your doctor about what you should do if you experience these or other side effects.
- back pain
- headaches
- nausea
- stomach upset or abdominal pain
Call your doctor or get medical help right away if you notice any of these more serious side effects:
- loss of balance
- bleeding or bruising
- changes in memory, mood, or thinking
- difficulty concentrating
- confusion
- swelling of the legs, feet, and hands
- fever or chills
- fast or irregular heart beats
- signs of liver damage (such as yellowing of eye or skin, dark urine, or unusual tiredness)
- memory problems or loss
- pale or blue skin, lips or fingernails
- red, burning, or itchy skin
- seizures
- skin changes - a darker area with uneven edges or coloring
- darkening of the skin
- change in the size or color of a skin mole
- skin sores
- difficulty speaking
- sweating at night
- sudden change or loss of vision
- unexpected or extreme weight loss
- slow wound healing
A few people may have an allergic reaction to this medicine. Symptoms can include difficulty breathing, skin rash, itching, swelling, or severe dizziness. If you notice any of these symptoms, seek medical help quickly.
Please speak with your doctor, nurse, or pharmacist if you have any questions about this medicine.
IMPORTANT NOTE: This document tells you briefly how to take your medicine, but it does not tell you all there is to know about it. Your doctor or pharmacist may give you other documents about your medicine. Please talk to them if you have any questions. Always follow their advice.
There is a more complete description of this medicine available in English. Scan this code on your smartphone or tablet or use the web address below. You can also ask your pharmacist for a printout. If you have any questions, please ask your pharmacist.
The display and use of this drug information is subject to Terms of Use.
More information about CLADRIBINE - ORAL
![](https://content.healthwise.net/resources/14.2/en-us/media/interface/fdb/fdbm26152-1907_en-us.png)
Copyright(c) 2024 First Databank, Inc.
Selected from data included with permission and copyright by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
Conditions of Use: The information in this database is intended to supplement, not substitute for the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. The display and use of this drug information is subject to express Terms of Use.